Mapping and direct valuation: do they give equivalent EQ-5D-5L index scores?

被引:16
|
作者
Luo, Nan [1 ]
Cheung, Yin Bun [2 ,3 ,4 ]
Ng, Raymond [5 ]
Lee, Chun Fan [2 ,3 ]
机构
[1] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore 117548, Singapore
[2] Duke NUS Grad Med Sch, Ctr Quantitat Med, Singapore, Singapore
[3] Singapore Clin Res Inst, Dept Biostat, Singapore, Singapore
[4] Univ Tampere, Dept Int Hlth, FIN-33101 Tampere, Finland
[5] Natl Canc Ctr, Dept Med Oncol, Singapore, Singapore
来源
基金
新加坡国家研究基金会; 英国医学研究理事会;
关键词
QUALITY-OF-LIFE; BREAST-CANCER PATIENTS; FUNCTIONAL ASSESSMENT; CHINESE VERSIONS; FACT-B; DIABETES PATIENTS; UTILITY INDEX; HEALTH; QUESTIONNAIRE; THERAPY;
D O I
10.1186/s12955-015-0361-y
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
Objective: Utility values of health states defined by health-related quality of life instruments can be derived from either direct valuation ('valuation-derived') or mapping ('mapping-derived'). This study aimed to compare the utility-based EQ-5D-5L index scores derived from the two approaches as a means to validating the mapping function developed by van Hout et al for the EQ-5D-5L instrument. Methods: This was an observational study of 269 breast cancer patients whose EQ-5D-5L index scores were derived from both methods. For comparing discriminatory ability and responsiveness to change, multivariable regression models were used to estimate the effect sizes of various health indicators on the index scores. Agreement and test-retest reliability were examined using intraclass correlation coefficient (ICC). Whenever appropriate, the 90 % confidence intervals (90 % CI) were compared to predefined equivalence margins. Results: The mean difference in and ICC between the valuation-and mapping-derived EQ-5D-5L index scores were 0.015 (90 % CI = 0.006 to 0.024) and 0.915, respectively. Discriminatory ability and responsiveness of the two indices were equivalent in 13 of 15 regression analyses. However, the mapping-derived index score was lower than the valuation-derived index score in patients experiencing extreme health problems, and the test-retest reliability of the former was lower than the latter, for example, their ICCs differed by 0.121 (90 % CI = 0.051 to 0.198) in patients who reported no change in performance status in the follow-up survey. Conclusion: This study provided the first evidence supporting the validity of the mapping function for converting EQ-5D-5L profile data into a utility-based index score.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] Mapping and direct valuation: do they give equivalent EQ-5D-5L index scores?
    Nan Luo
    Yin Bun Cheung
    Raymond Ng
    Chun Fan Lee
    Health and Quality of Life Outcomes, 13
  • [2] Valuation of the EQ-5D-5L in Taiwan
    Lin, Hsiang-Wen
    Li, Chia-Ing
    Lin, Fang-Ju
    Chang, Jen-Yu
    Gau, Churn-Shiouh
    Luo, Nan
    Pickard, A. Simon
    Goni, Juan M. Ramos
    Tang, Chao-Hsiun
    Hsu, Chien-Ning
    PLOS ONE, 2018, 13 (12):
  • [3] Normative profile of the EQ-5D-5L dimensions, EQ-5D-5L index and EQ-VAS scores for the general Thai population
    Krittaphas Kangwanrattanakul
    Quality of Life Research, 2023, 32 : 2489 - 2502
  • [5] EQ-5D-5L valuation study for Portugal
    Ferreira, Pedro L.
    Antunes, Patricia
    Ferreira, Lara N.
    Pereira, Luis N.
    QUALITY OF LIFE RESEARCH, 2017, 26 (01) : 87 - 87
  • [6] The EQ-5D-5L valuation study in Korea
    Seon-Ha Kim
    Jeonghoon Ahn
    Minsu Ock
    Sangjin Shin
    Jooyeon Park
    Nan Luo
    Min-Woo Jo
    Quality of Life Research, 2016, 25 : 1845 - 1852
  • [7] Peruvian Valuation of the EQ-5D-5L: A Direct Comparison of cTTO and DCE
    Augustovski, Federico
    Belizan, Maria
    Gibbons, Luz
    Reyes, Nora
    Stolk, Elly
    Craig, Benjamin M.
    Tejada, Romina A.
    PATIENT-PATIENT CENTERED OUTCOMES RESEARCH, 2020, 13 (01): : 140 - 141
  • [8] EQ-5D-5L Valuation for the Malaysian Population
    Shafie, Asrul Akmal
    Thakumar, Annushiah Vasan
    Lim, Ching Jou
    Luo, Nan
    Rand-Hendriksen, Kim
    Yusof, Faridah Aryani Md
    PHARMACOECONOMICS, 2019, 37 (05) : 715 - 725
  • [9] EQ-5D-5L VALUATION STUDY IN TAIWAN
    Lin, H.
    Li, C.
    Lin, F.
    Chang, J.
    Gau, C.
    Luo, N.
    Pickard, A. S.
    Goni, Ramos J. M.
    Tang, C.
    Hsu, C.
    VALUE IN HEALTH, 2018, 21 : S91 - S91
  • [10] EQ-5D-5L Valuation for the Malaysian Population
    Asrul Akmal Shafie
    Annushiah Vasan Thakumar
    Ching Jou Lim
    Nan Luo
    Kim Rand-Hendriksen
    Faridah Aryani Md Yusof
    PharmacoEconomics, 2019, 37 : 715 - 725